Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
VANCOUVER, British Columbia, April 17, 2019 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that recent characterization work with Cannabix’s FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device with human subjects has shown the ability to consistently discriminate unwanted ions from complex human breath background matrices allowing for THC (∆9-tetrahydrocannabinol) detection. In particular, recent testing with updated FAIMS cell geometries has shown the ability to consistently supress several compounds that are commonly found in breath like nicotine, garlic, onion, meats, ethanol, and volatile flavorants such as methyl salicylate and menthol (commonly found in gum) allowing for discrimination and mobility of THC in exhaled breath.
- Published: 17 April 2019
- Written by Editor